Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome, results expected in Q3/2015
12-Jan-2015 -
Herantis Pharma Plc. has initiated its Phase 2 clinical study with Cis-UCA Eye Drops in patients with Dry Eye Syndrome. In the study, 150 patients with Dry Eye Syndrome will be randomized to receive 4 weeks of treatment with either placebo eye drops or two different strengths of cis-UCA Eye ...
dry eye syndrome
phase II studies